OMAR AHMED

Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology NEW YORK, NY NPI 1831517002

General Payments — all program years on this page

$3,289.36

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 98
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $907.12 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $473.1216
Travel and Lodging $434.003

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
INTUITIVE SURGICAL, INC. $434.003
ABBVIE INC. $209.359
Neurocrine BioSciences, Inc. $112.911
Lilly USA, LLC $60.393
CeQur Corporation $33.091
Ultragenyx Pharmaceutical Inc. $29.531
PFIZER INC. $27.851

By program year

Program yearAmountRecords
2018 $47.602
2019 $272.9611
2020 $211.4110
2021 $452.3719
2022 $810.1124
2023 $587.7913
2024 $907.1219

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1103186288 ABBVIE INC. $31.57 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103186290 ABBVIE INC. $7.83 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103186292 ABBVIE INC. $11.08 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103186294 ABBVIE INC. $30.97 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103186296 ABBVIE INC. $34.00 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103186298 ABBVIE INC. $15.51 08/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103186300 ABBVIE INC. $28.73 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103186302 ABBVIE INC. $16.74 09/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103186304 ABBVIE INC. $32.92 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126847088 CeQur Corporation $33.09 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131947772 PFIZER INC. $27.85 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135252502 Lilly USA, LLC $22.13 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135256114 Lilly USA, LLC $23.00 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135261348 Lilly USA, LLC $15.26 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137192180 INTUITIVE SURGICAL, INC. $19.00 07/30/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137225332 INTUITIVE SURGICAL, INC. $196.86 09/07/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1137286321 INTUITIVE SURGICAL, INC. $218.14 07/30/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1150811084 Neurocrine Biosciences, Inc. $112.91 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153281923 Ultragenyx Pharmaceutical Inc. $29.53 05/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.